参考文献/References:
[1] Budohoski KP, Guilfoyle M, Helmy A, et al. The pathophy-siology and treatment of delayed cerebral ischaemia follow-ing subarachnoid haemorrhage [J]. J Neurol Neurosurg Psychiatry, 2014, 85: 1343-1353.
[2] Fadar Otite MD, Susanne Mink MD, Can Ozan Tan, et al. Impaired cerebral autoregulation is associated with vaso-spasm and delayed cerebral ischemia in subarachnoid hemorrhage [J]. Stroke, 2014, 45(3): 677-682.
[3] Velat GJ, Kimball MM, Mocco JD, et al. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomizedcontrolled trials and meta-analyses in the literature [J]. World Neurosurg, 2011, 76(5): 446-454.
[4] Liu GJ, Luo J, Zhang LP, et al. Meta-analysis of the effec-tiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage [J]. CNS Neurol Disord Drug Targets, 2011, 10(7): 834-844.
[5] Adamczyk P, He S, Amar AP, et al. Medical Management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a review of current and emerging therapeutic interventions [J]. Neurol Res Int, 2013, 2013: 462-491.
[6] Heffren J, McIntosh AM, Reiter PD. Nimodipine for the pre-vention of cerebral vasospasm after subarachnoid hemorr-hage in 12 children [J]. Pediatr Neurol, 2015, 52: 356-360.
[7] Ott S, Jedlicka S, Wolf S, et al. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage [J]. Biomed Res Int, 2014, 2014: 741-970.
[8] Seker F, Hesser J, Neumaier-Probst E, et al. Dose-responserelationship of locally applied nimodipine in an exvivo model of cerebral vasospasm [J]. Neuroradiology, 2013, 55(1): 71-76.
[9] Kim SS, Park DH, Lim DJ, et al. Angiographic features and clinical outcomes of intra-arterial nimodipine injection in patients with subarachnoid hemorrhage-induced vasospasm [J]. J Korean Neurosurg Soc, 2012, 52(3): 172-178.
[10] Aburto-Murrieta Y, Marquez-Romero JM, Bonifacio-Del-gadillo D, et al. Endovascular treatment: balloon angiopla-sty versus nimodipine intra-arterial for medically refractory cerebral vasospasm following aneurysmal subarachnoid he-morrhage [J]. Vasc Endovascular Surg, 2012, 46: 460-465.
[11] Onal MB, Solmaz I, Civelek E, et al. Comparison of intrathe-cal dotarizine and nimodipine treatments in cerebral vasos-pasm after subarachnoid hemorrhage: an experimental study in rabbits [J]. Acta Neurochir Suppl, 2011, 110(Pt 2): 55-60.
[12] Bege N, Renette T, Endres T, et al. In situ forming nimodi-pine depot system based on microparticles for the treatment of posthemorrhagic cerebral vasospasm [J]. Eur J Pharm Biopharm, 2013, 84(1): 99-105.
[13] H?nggi D, Etminan N, Macdonald RL, et al. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage [J]. Neurocrit Care, 2015, 13: 78-99.
[14] Koskim?ki J, Tarkia M, Ahtola-S?til? T, et al. Intracranial biodegradable silica-based nimodipine drug release implantfor treating vasospasm in subarachnoid hemorrhage in an experimental healthy pig and dog model [J]. Biomed Res Int, 2015, 2015: 715-752.
[15] Cook DJ, Kan S, Ai J, et al. Cisternal sustained release dihydropyridines for subarachnoid hemorrhage [J]. Curr Neurovasc Res, 2012, 9(2): 139-148.
[16] Cook DJ, Kan S, Ai J, et al. Cisternal sustained release dihydropyridines for subarachnoid hemorrhage [J]. Curr Neurovasc Res, 2012, 9(2): 139-148.
[17] Nikitina E, Kawashima A, Takahashi M, et al. Alteration in voltage-dependent calcium channels in dog basilar artery after subarachnoid hemorrhage [J]. J Neurosurg, 2010, 113(4): 870-880.
[18] Onal MB, Solmaz I, Civelek E, et al. Comparison of intrathe-cal dotarizine and nimodipine treatments in cerebral vasos-pasm after subarachnoid hemorrhage: an experimental study in rabbits [J]. Acta Neurochir Suppl, 2011, 110(Pt 2): 55-60.
[19] Musahl C, Henkes H, Vajda Z, et al. Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage [J]. Neurosurgery,2011, 68(6): 1541-1547.
[20] Wang F, Yin YH, Jia F, et al. Antagonism of R-type calciumchannels significantly improves cerebral blood flow after subarachnoid hemorrhage in rats [J]. J Neurotrauma, 2010, 27(9): 1723-1732.
[21] Song JN, Yan WT, An JY, et al. Potential contribution of SOCC to cerebral vasospasm after experimental subarach-noid hemorrhage in rats [J]. Brain Res, 2013, 1517: 93-103.
相似文献/References:
[1]旷仁钊 唐晓平 漆 建 苟章洋.丹红注射液对大鼠蛛网膜下腔出血后脑血管痉挛的影响[J].中国临床神经外科杂志,2015,(11):683.[doi:10.13798/j.issn.1009-153X.2015.11.014]
KUANG Ren-zhao,TANG Xiao-ping,QI Jian,et al.Effects of Danhong on cerebral vasospasm after subara- chnoid hemorrhage in rats[J].,2015,(02):683.[doi:10.13798/j.issn.1009-153X.2015.11.014]
[2]周路桥 罗富强 彭 虎 邱成元 刘 苏 蒋国辉 田 强 罗荣武.皮瓣塌陷综合征患者颅骨修补术后继发蛛网膜下腔出血1例[J].中国临床神经外科杂志,2015,(11):704.[doi:10.13798/j.issn.1009-153X.2015.11.022]
[3]曾 春 张施远 蒋永明.复合手术与常规夹闭术治疗颈内动脉后交通动脉破裂动脉瘤的疗效对比研究[J].中国临床神经外科杂志,2016,(05):257.[doi:10.13798/j.issn.1009-153X.2016.05.001]
ZENG Chun,ZHANG Shi-yuan,JIANG Yong-ming.Analysis of the effects of hybrid surgery on posterior communicating artery aneurysms: a comparison with conventional craniotomy[J].,2016,(02):257.[doi:10.13798/j.issn.1009-153X.2016.05.001]
[4]周有东 敖祥生 刘汉东 王志勇 朱耀祖 周达全.支架辅助弹簧圈和单纯弹簧圈栓塞治疗颅内动脉瘤疗效及安全性的Meta分析[J].中国临床神经外科杂志,2016,(05):274.[doi:10.13798/j.issn.1009-153X.2016.05.006]
ZHOU You-dong,AO Xiang-sheng,LIU Han-dong,et al.A mata-analysis of curative effects of stent-assisted coiling and simple coiling on intracranial aneurysms and their safety[J].,2016,(02):274.[doi:10.13798/j.issn.1009-153X.2016.05.006]
[5]赵 平 王雄伟 汪 雷 马金阳.显微手术和血管内栓塞术治疗颅内动脉瘤的疗效分析[J].中国临床神经外科杂志,2016,(05):281.[doi:10.13798/j.issn.1009-153X.2016.05.008]
ZHAO Ping,WANG Xiong-wei,WANG Lei,et al.Effect of endovascular treatment on intracranial aneurysms: a comparison with microsurgery[J].,2016,(02):281.[doi:10.13798/j.issn.1009-153X.2016.05.008]
[6]刘福德 邓剑平 张 涛 陈 虎 李 帅 王俭博 曲友直 赵振伟.椎-基底动脉夹层动脉瘤的血管内治疗（附48例分析）[J].中国临床神经外科杂志,2016,(06):353.[doi:10.13798/j.issn.1009-153X.2016.06.011]
LIU Fu-de,DENG Jian-ping,ZHANG Tao,et al.Endovascular treatment of vertebrobasilar artery dissecting aneurysms (report of 48 cases)[J].,2016,(02):353.[doi:10.13798/j.issn.1009-153X.2016.06.011]
[7]余龙洋 李亚楠 周 宇 戴冬伟 曹依群 岳志健.垂体腺瘤经蝶术后并发蛛网膜下腔出血的临床分析
（附6例报道）[J].中国临床神经外科杂志,2016,(06):372.[doi:10.13798/j.issn.1009-153X.2016.06.018]
[8]吴有志 罗良生 张 健 陈 骅 吴 鸣 刘 振 史 岩.前循环破裂动脉瘤伴脑内血肿的
早期显微手术治疗[J].中国临床神经外科杂志,2016,(06):376.[doi:10.13798/j.issn.1009-153X.2016.06.020]
[9]潘 力 刘 鹏 秦 杰 杨 柳 安学峰 吴 虓 杨 铭 徐国政 马廉亭.Y型支架辅助技术在颅内动脉分叉部宽颈动脉瘤治疗中的应用[J].中国临床神经外科杂志,2016,(07):394.[doi:10.13798/j.issn.1009-153X.2016.07.002]
PAN Li,LIU Peng,QIN Jie,et al.Application of Y -configuration stent technique to treatment of intracranial wide-neck bifurcation aneurysms[J].,2016,(02):394.[doi:10.13798/j.issn.1009-153X.2016.07.002]
[10]张 莹 荆林凯 张倩倩 刘 健 张义森 王 坤 穆士卿 杨新健.颈内动脉后交通动脉小动脉瘤破裂危险因素分析[J].中国临床神经外科杂志,2016,(03):138.[doi:10.13798/j.issn.1009-153X.2016.03.002]
ZHANG Ying,JING Lin-kai,ZHANG Qian-qian,et al.Analysis of risk factors related to rupture of small (diameter ≤5 mm) posterior communicating artery aneurysms[J].,2016,(02):138.[doi:10.13798/j.issn.1009-153X.2016.03.002]
[11]李朝晖 王玉贵 张孟超 综述 赵兴利 审校.CT灌注成像在动脉瘤性蛛网膜下腔出血中的
临床应用进展[J].中国临床神经外科杂志,2016,(05):313.[doi:10.13798/j.issn.1009-153X.2016.05.021]
[12]周 量 刘 丛 张昌伟.早期栓塞术治疗动脉瘤性蛛网膜下腔出血的疗效[J].中国临床神经外科杂志,2016,(07):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
ZHOU Liang,LIU Cong,ZHANG Chang-wei..Curative effect of early endovascular embolization on patients with ruptured intracranial aneurysms[J].,2016,(02):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
[13]朱作磊 综述 罗良生 审校.动脉瘤性蛛网膜下腔出血的预后相关因素研究进展[J].中国临床神经外科杂志,2016,(03):183.[doi:10.13798/j.issn.1009-153X.2016.03.020]
[14]祝 源 李 俊 陈 刚 向伟楚 李国栋 赵曰圆 李欢欢 汤 伟 金二亮 马廉亭.两次DSA阴性的颅内破裂动脉瘤1例报道并文献复习[J].中国临床神经外科杂志,2015,(09):538.[doi:10.13798/j.issn.1009-153X.2015.09.009]
ZHU Yuan,LI Jun,CHEN Gang,et al.Both negative DSA findings in 1 patient with ruptured intracranial aneurysm (case report and review of literature)[J].,2015,(02):538.[doi:10.13798/j.issn.1009-153X.2015.09.009]
[15]刘骏辉 综述 陈谦学 审校.动脉瘤性蛛网膜下腔出血后抗血管痉挛的药物治疗[J].中国临床神经外科杂志,2016,(08):504.[doi:10.13798/j.issn.1009-153X.2016.08.024]
[16]焦 猛 综述 窦长武 审校.动脉瘤性蛛网膜下腔出血后脑积水的危险因素[J].中国临床神经外科杂志,2017,(04):273.[doi:10.13798/j.issn.1009-153X.2017.04.027]
[17]闵 杰 王 仙 张 双 杨 磊 陈世洁.多囊肾合并动脉瘤性蛛网膜下腔出血1例[J].中国临床神经外科杂志,2017,(08):548.[doi:10.13798/j.issn.1009-153X.2017.08.008]
[18]杨洪宽 陈 豪 陈如东 厉 华 于加省 雷 霆.大脑前动脉A1段动脉瘤的临床特点及治疗（附8例分析）[J].中国临床神经外科杂志,2017,(09):613.[doi:10.13798/j.issn.1009-153X.2017.09.002]
YANG Hong-kuan,CHEN Hao,CHEN Ru-dong,et al.Clinical characteristics and treatment of aneurysms arising from anterior cerebral artery A1 segment[J].,2017,(02):613.[doi:10.13798/j.issn.1009-153X.2017.09.002]
[19]陈华轩 张 渊 王 林 宋旭东 刘 毅 范润金.缺血修饰白蛋白对动脉瘤性蛛网膜下腔出血后脑血管痉挛的评估价值[J].中国临床神经外科杂志,2019,(01):26.[doi:10.13798/j.issn.1009-153X.2019.01.007]
CHEN Hua-xuan,ZHANG Yuan,WANG Lin,et al.Value of ischemia-modified albumin to assesment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage[J].,2019,(02):26.[doi:10.13798/j.issn.1009-153X.2019.01.007]
[20]谭占国 黄圣明.蛛网膜下腔出血后迟发脑血管痉挛诊治新进展[J].中国临床神经外科杂志,2019,(08):505.[doi:10.13798/j.issn.1009-153X.2019.08.020]